191 related articles for article (PubMed ID: 25060425)
1. Pleomorphic adenoma gene 1 mediates the role of karyopherin alpha 2 and has prognostic significance in hepatocellular carcinoma.
Hu ZY; Yuan SX; Yang Y; Zhou WP; Jiang H
J Exp Clin Cancer Res; 2014 Jul; 33(1):61. PubMed ID: 25060425
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of nuclear KPNA2 is correlated with early recurrence and poor prognosis in patients with small hepatocellular carcinoma after hepatectomy.
Jiang P; Tang Y; He L; Tang H; Liang M; Mai C; Hu L; Hong J
Med Oncol; 2014 Aug; 31(8):131. PubMed ID: 25031071
[TBL] [Abstract][Full Text] [Related]
3. Upregulated KPNA2 promotes hepatocellular carcinoma progression and indicates prognostic significance across human cancer types.
Guo X; Wang Z; Zhang J; Xu Q; Hou G; Yang Y; Dong C; Liu G; Liang C; Liu L; Zhou W; Liu H
Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):285-292. PubMed ID: 30883648
[TBL] [Abstract][Full Text] [Related]
4. Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.
Drucker E; Holzer K; Pusch S; Winkler J; Calvisi DF; Eiteneuer E; Herpel E; Goeppert B; Roessler S; Ori A; Schirmacher P; Breuhahn K; Singer S
Cell Commun Signal; 2019 Nov; 17(1):159. PubMed ID: 31783876
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-139 inhibits hepatocellular carcinoma cell growth through down-regulating karyopherin alpha 2.
Zan Y; Wang B; Liang L; Deng Y; Tian T; Dai Z; Dong L
J Exp Clin Cancer Res; 2019 May; 38(1):182. PubMed ID: 31046781
[TBL] [Abstract][Full Text] [Related]
6. Silencing of karyopherin α2 inhibits cell growth and survival in human hepatocellular carcinoma.
Yang Y; Guo J; Hao Y; Wang F; Li F; Shuang S; Wang J
Oncotarget; 2017 May; 8(22):36289-36304. PubMed ID: 28422734
[TBL] [Abstract][Full Text] [Related]
7. Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer.
Altan B; Yokobori T; Mochiki E; Ohno T; Ogata K; Ogawa A; Yanai M; Kobayashi T; Luvsandagva B; Asao T; Kuwano H
Carcinogenesis; 2013 Oct; 34(10):2314-21. PubMed ID: 23749771
[TBL] [Abstract][Full Text] [Related]
8. Novel roles of karyopherin subunit alpha 2 in hepatocellular carcinoma.
Yang X; Wang H; Zhang L; Yao S; Dai J; Wen G; An J; Jin H; Du Q; Hu Y; Zheng L; Chen X; Yi Z; Tuo B
Biomed Pharmacother; 2023 Jul; 163():114792. PubMed ID: 37121148
[TBL] [Abstract][Full Text] [Related]
9. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
10. High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
Shi B; Su B; Fang D; Tang Y; Xiong G; Guo Z; He Q; Yang X; Zhao W; Guo Y; Li X; Zhou L
BMC Cancer; 2015 May; 15():380. PubMed ID: 25956057
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins.
Tsukagoshi M; Araki K; Yokobori T; Altan B; Suzuki H; Kubo N; Watanabe A; Ishii N; Hosouchi Y; Nishiyama M; Shirabe K; Kuwano H
Oncotarget; 2017 Jun; 8(26):42159-42172. PubMed ID: 28178675
[TBL] [Abstract][Full Text] [Related]
12. Identification of a karyopherin alpha 2 recognition site in PLAG1, which functions as a nuclear localization signal.
Braem CV; Kas K; Meyen E; Debiec-Rychter M; Van De Ven WJ; Voz ML
J Biol Chem; 2002 May; 277(22):19673-8. PubMed ID: 11882654
[TBL] [Abstract][Full Text] [Related]
13. Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1β-induced matrix metalloproteinase expression in oral cancer.
Wang CI; Yu CJ; Huang Y; Yi JS; Cheng HW; Kao HK; Lao WW; Chang KP
Head Neck; 2018 Aug; 40(8):1719-1733. PubMed ID: 29542209
[TBL] [Abstract][Full Text] [Related]
14. Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.
Wang CI; Chien KY; Wang CL; Liu HP; Cheng CC; Chang YS; Yu JS; Yu CJ
Mol Cell Proteomics; 2012 Nov; 11(11):1105-22. PubMed ID: 22843992
[TBL] [Abstract][Full Text] [Related]
15. KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer.
Alshareeda AT; Negm OH; Green AR; Nolan CC; Tighe P; Albarakati N; Sultana R; Madhusudan S; Ellis IO; Rakha EA
Br J Cancer; 2015 Jun; 112(12):1929-37. PubMed ID: 25989275
[TBL] [Abstract][Full Text] [Related]
16. Expression of Karyopherin Alpha 2 and Karyopherin Beta 1 Correlate with Poor Prognosis in Gastric Cancer.
Ohhara Y; Kinoshita I; Suzuki A; Imagawa M; Taguchi J; Noguchi T; Takeuchi S; Shimizu Y; Seki H; Suzuki J; Dosaka-Akita H
Oncology; 2022; 100(12):685-695. PubMed ID: 36273446
[TBL] [Abstract][Full Text] [Related]
17. Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer.
Jeong D; Kim H; Ban S; Oh S; Ji S; Kim D; Ahn TS; Kim HJ; Bae SB; Kwon HY; Im J; Lee MS; Cho HD; Kim CJ; Baek MJ
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2493-2503. PubMed ID: 28875407
[TBL] [Abstract][Full Text] [Related]
18. KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas.
Gousias K; Niehusmann P; Gielen G; Simon M; Boström J
J Clin Neurosci; 2014 Oct; 21(10):1719-24. PubMed ID: 24929863
[TBL] [Abstract][Full Text] [Related]
19. Karyopherin α 2 promotes proliferation, migration and invasion through activating NF-κB/p65 signaling pathways in melanoma cells.
Yang F; Li S; Cheng Y; Li J; Han X
Life Sci; 2020 Jul; 252():117611. PubMed ID: 32243925
[TBL] [Abstract][Full Text] [Related]
20. KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma and correlates with cell proliferation.
Ma S; Zhao X
Oncol Rep; 2014 Oct; 32(4):1631-7. PubMed ID: 25109899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
